Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Implanted phrenic nerve stimulator for central sleep apnea

Número de PMA: P160039 · 2025-05-07

SolicitanteRespicardia
Fecha de decisión2025-05-07
Número PMAP160039
Código de productoPSR
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorAN

Resumen del dispositivo

Implanted phrenic nerve stimulator for central sleep apnea is the device name listed in this FDA 510(k) record. The listed applicant is Respicardia. It received FDA 510(k) clearance on 2025-05-07. The device is classified under product code PSR. It was reviewed by the AN advisory panel.

Preguntas frecuentes

What is the Implanted phrenic nerve stimulator for central sleep apnea?

Implanted phrenic nerve stimulator for central sleep apnea is a medical device that received FDA 510(k) clearance on 2025-05-07. The listed applicant is Respicardia.

When did Implanted phrenic nerve stimulator for central sleep apnea receive FDA 510(k) clearance?

The clearance date for Implanted phrenic nerve stimulator for central sleep apnea can be found in the official FDA records.

Who is the listed applicant for Implanted phrenic nerve stimulator for central sleep apnea?

The FDA 510(k) record lists Respicardia as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Implanted phrenic nerve stimulator for central sleep apnea?

The FDA product code for Implanted phrenic nerve stimulator for central sleep apnea is PSR.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑